Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CVRX NASDAQ:GUTS NYSE:INFU NASDAQ:KRMD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCVRXCVRx$7.85-0.4%$7.28$4.30▼$18.55$205.29M1.27269,874 shs116,971 shsGUTSFractyl Health$0.97-1.9%$1.45$0.83▼$3.72$48.84M1.661.46 million shs560,353 shsINFUInfuSystem$10.78+0.5%$7.20$4.61▼$11.04$220.19M1.81176,357 shs314,045 shsKRMDKORU Medical Systems$4.22-0.2%$3.71$1.86▼$5.05$195.11M0.47126,133 shs89,982 shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCVRXCVRx0.00%+0.64%-1.38%+18.58%-20.95%GUTSFractyl Health0.00%-4.78%-47.22%-49.68%-71.18%INFUInfuSystem0.00%+12.64%+92.50%+86.51%+66.62%KRMDKORU Medical Systems0.00%-3.65%+21.97%+52.35%+72.95%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCVRXCVRx2.5041 of 5 stars3.41.00.00.03.32.50.6GUTSFractyl Health2.3048 of 5 stars3.52.00.00.03.41.70.0INFUInfuSystem2.6802 of 5 stars1.05.00.00.02.63.32.5KRMDKORU Medical Systems1.0908 of 5 stars1.52.00.00.02.82.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCVRXCVRx 2.86Moderate Buy$14.0078.34% UpsideGUTSFractyl Health 3.00Buy$6.53572.71% UpsideINFUInfuSystem 4.00Strong Buy$12.5015.96% UpsideKRMDKORU Medical Systems 3.00Buy$4.639.60% UpsideCurrent Analyst Ratings BreakdownLatest GUTS, CVRX, KRMD, and INFU Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/28/2025GUTSFractyl HealthLADENBURG THALM/SH SHSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$3.608/14/2025GUTSFractyl HealthCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$12.00 ➝ $6.008/5/2025CVRXCVRxCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$11.007/22/2025INFUInfuSystemRoth CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$12.007/21/2025INFUInfuSystemRoth CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy7/7/2025CVRXCVRxWilliam BlairSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy(Data available from 8/31/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCVRXCVRx$51.29M4.00N/AN/A$2.22 per share3.54GUTSFractyl Health$17K2,872.98N/AN/A($0.36) per share-2.70INFUInfuSystem$139.89M1.57$0.84 per share12.79$2.47 per share4.36KRMDKORU Medical Systems$33.65M5.80N/AN/A$0.36 per share11.72Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCVRXCVRx-$59.97M-$2.10N/AN/AN/A-95.61%-79.31%-40.96%11/4/2025 (Estimated)GUTSFractyl Health-$68.69M-$2.06N/AN/AN/A-73,864.52%-584.35%-102.88%11/11/2025 (Estimated)INFUInfuSystem$870K$0.23179.7034.77N/A1.12%2.78%1.41%N/AKRMDKORU Medical Systems-$6.07M-$0.09N/AN/AN/A-12.24%-26.77%-16.81%11/12/2025 (Estimated)Latest GUTS, CVRX, KRMD, and INFU EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/12/2025Q2 2025GUTSFractyl Health-$0.37-$0.53-$0.16-$0.57N/AN/A8/6/2025Q2 2025KRMDKORU Medical Systems-$0.03$0.01+$0.04N/A$9.46 million$10.20 million8/4/2025Q2 2025CVRXCVRx-$0.52-$0.57-$0.05-$0.57$13.22 million$13.59 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCVRXCVRxN/AN/AN/AN/AN/AGUTSFractyl HealthN/AN/AN/AN/AN/AINFUInfuSystemN/AN/AN/AN/AN/AKRMDKORU Medical SystemsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCVRXCVRx0.8511.9910.78GUTSFractyl Health4.611.221.22INFUInfuSystem0.501.981.59KRMDKORU Medical Systems0.012.912.25Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCVRXCVRx75.27%GUTSFractyl HealthN/AINFUInfuSystem71.13%KRMDKORU Medical Systems58.60%Insider OwnershipCompanyInsider OwnershipCVRXCVRx13.90%GUTSFractyl Health27.00%INFUInfuSystem11.40%KRMDKORU Medical Systems20.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCVRXCVRx16026.15 million22.52 millionOptionableGUTSFractyl Health10250.29 million36.71 millionN/AINFUInfuSystem41020.43 million19.10 millionOptionableKRMDKORU Medical Systems8046.24 million36.71 millionOptionableGUTS, CVRX, KRMD, and INFU HeadlinesRecent News About These CompaniesTopline Capital Management LLC Reduces Holdings in KORU Medical Systems, Inc. $KRMDAugust 30 at 8:04 AM | marketbeat.comAre You Looking for a Top Momentum Pick? Why KORU Medical Systems, Inc. (KRMD) is a Great ChoiceAugust 28 at 1:00 PM | zacks.comCirtec Medical Announces Appointment of New Chief Executive OfficerAugust 28 at 12:59 PM | globenewswire.comKORU Medical Systems (NASDAQ:KRMD) Trading Up 0.7% - Still a Buy?August 23, 2025 | marketbeat.comKORU Medical Systems (NASDAQ:KRMD) Is In A Strong Position To Grow Its BusinessAugust 9, 2025 | finance.yahoo.comKORU Medical Systems Inc (KRMD) Q2 2025 Earnings Report Preview: What To ExpectAugust 7, 2025 | finance.yahoo.comKORU Medical Systems, Inc. (KRMD) Q2 2025 Earnings Call TranscriptAugust 7, 2025 | seekingalpha.comKORU Medical Systems, Inc. (KRMD) Reports Break-Even Earnings for Q2August 6, 2025 | zacks.comKORU Medical Systems Announces Q2 2025 Financial Results, Including Record Double-digit Revenue, and Raises 2025 Revenue GuidanceAugust 6, 2025 | businesswire.comKORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)August 1, 2025 | businesswire.comKORU Medical Systems (KRMD) Expected to Announce Earnings on WednesdayJuly 31, 2025 | marketbeat.comKORU Medical Systems to Participate in the Canaccord Genuity 45th Annual Growth ConferenceJuly 30, 2025 | businesswire.comKORU Medical Systems Appoints Adam Kalbermatten as Chief Commercial Officer - MorningstarJuly 9, 2025 | morningstar.comMKORU Medical Systems Appoints Adam Kalbermatten as Chief Commercial OfficerJuly 7, 2025 | businesswire.comKRMD KORU Medical Systems, Inc. - Seeking AlphaJune 28, 2025 | seekingalpha.comKORU Medical Systems to join Russell 3000 and 2000 indexesJune 11, 2025 | msn.comKORU Medical Systems to Join Russell 3000® and Russell 2000® IndexesJune 11, 2025 | businesswire.comKORU Medical Systems holds annual shareholder meetingMay 17, 2025 | uk.investing.comKORU Medical Systems, Inc. (NASDAQ:KRMD) Q1 2025 Earnings Call TranscriptMay 13, 2025 | msn.comKORU Medical Systems, Inc. (KRMD) Q1 2025 Earnings Call TranscriptMay 11, 2025 | seekingalpha.comHere's What Analysts Are Forecasting For KORU Medical Systems, Inc. (NASDAQ:KRMD) After Its First-Quarter ResultsMay 10, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeGUTS, CVRX, KRMD, and INFU Company DescriptionsCVRx NASDAQ:CVRX$7.85 -0.03 (-0.38%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$7.84 -0.01 (-0.19%) As of 08/29/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.Fractyl Health NASDAQ:GUTS$0.97 -0.02 (-1.90%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$0.99 +0.02 (+2.35%) As of 08/29/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.InfuSystem NYSE:INFU$10.78 +0.05 (+0.47%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$10.78 0.00 (-0.05%) As of 08/29/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.KORU Medical Systems NASDAQ:KRMD$4.22 -0.01 (-0.24%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$4.22 +0.00 (+0.12%) As of 08/29/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 08/25 - 08/29 Ollie’s Bargain Outlet: Buy it While It’s Still a Bargain Tencent Music Stock Outshines Spotify as China’s Music Giant Best Buy Marketplace: Potential Growth Catalyst or Risky Gimmick? DICKS’s Sporting Goods Stock Dropped After Earnings—Is It a Buy? CrowdStrike at a Crossroads: AI Halo vs. Risks Snowflake’s Snowballing Business and Robust Stock Price Outlook NVIDIA's Earnings Show a Green Light for Taiwan Semiconductor Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
